PlainPharmaWatch

CMS Open Payments · Program Year 2024

Nebraska

Nebraska received $9,323,591.67 in pharmaceutical-industry payments to 4,603 physicians and 10 teaching hospitals across 102,911 transactions.

$9.3M
Total payments
$7.1M
To physicians
$527.7K
To teaching hospitals
#40
of 59 states

In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $9.3M in payments to 4,603 physicians and 10 teaching hospitals in Nebraska. That ranks Nebraska #40 of 59 states and territories (0.1% of the US total), averaging $1.5K per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

The verdict

Nebraska pairs below-median payment volume with a physician-heavy payment mix.

#40
of 59 states
0.1%
of the national total
76.4%
to physicians vs. hospitals
4,603
physicians paid

What the Data Shows for Nebraska

Nebraska sits in the middle volume tercile at #40 of 59 (0.1% of US dollars), with $9,323,591.67 reaching 4,603 physicians and 10 teaching hospitals.

Physician versus hospital mix is near the corpus middle (76.4% / 5.7%). Average transaction $90.60. Leading nature of payment: "Compensation for Services Other Than Consulting" at $2.5M (27.1% of the state file; top-three natures 74.9%).

Nebraska sits in the 34th percentile (lower-volume tier). Just above: New Hampshire ($9.4M). Just below: West Virginia ($8.3M). For context: top-ranked California ($342.4M) is 36.7× larger than Nebraska. CMS Sunshine Act framework and methodology.

Physician vs Hospital Payments

How pharmaceutical payments in Nebraska are distributed between physicians and teaching hospitals.

Physician Payments

$7.1M

76.4% of total · 4,603 recipients · $1.5K avg

Teaching Hospital Payments

$527.7K

5.7% of total · 10 hospitals · $52.8K avg

Payment Breakdown by Type

Nebraska has 15 types of pharmaceutical payments. "Compensation for Services Other Than Consulting" accounts for 27.1%.

Nature concentration in Nebraska

Top three Open Payments natures are 74.9% of state dollars; residual is every other reported nature

Compensation for Services Ot…$2.5MFood and Beverage$2.3MConsulting Fee$2.1MAll other natures (12)$2.3M

Payment categories in Nebraska

Top categories by total reported dollar volume

1. Compensation for Services…$2.5M2. Food and Beverage$2.3M3. Consulting Fee$2.1M4. Travel and Lodging$1.1M5. Royalty or License$282.0K6. Space Rental or Facility …$197.2K7. Education$186.0K8. Grant$178.5K9. Honoraria$174.7K10. Long-Term Medical Supply…$73.4K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $2.5M 1,188
Food and Beverage $2.3M 95,765
Consulting Fee $2.1M 827
Travel and Lodging $1.1M 3,562
Royalty or License $282.0K 27
Space Rental or Facility Fees $197.2K 34
Education $186.0K 1,016
Grant $178.5K 23
Honoraria $174.7K 91
Long-Term Medical Supply or Device Loan $73.4K 73
Compensation for Faculty or Speaker (Medical Education) $47.0K 42
Gift $41.9K 207
Debt Forgiveness $31.2K 24
Charitable Contribution $4.0K 2
Entertainment $3.6K 30

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024

What Nebraska totals can and cannot tell you

The aggregate payment figure for Nebraska measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.

Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.

View saved (states)
Download Nebraska's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.